280It must be borne in mind that the Commission must be recognised as enjoying a broad discretion when it adopts, in the context of the procedure to include a substance in Annex I to Directive 91/414, risk-management measures. That domain involves, inter alia, political choices and complex assessments on its part (see paragraph 86 above). The legality of such a measure can be affected only if the measure is manifestly inappropriate in terms of the objective which the competent institution is seeking to pursue (Case C-189/01 Jippes and Others [2001] ECR I-5689, paragraph 82; Pfizer Animal Health v Council, cited in paragraph 145 above, paragraph 412; and Alpharma v Council, cited in paragraph 145 above, paragraphs 177 to 180).
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.